Quanterix Corp

NASDAQ:QTRX  
50.27
+2.56 (+5.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.93B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$23.41 Million
Adjusted EPS-$0.35
See more estimates
10-Day MA$48.56
50-Day MA$51.16
200-Day MA$57.95
See more pivots

Quanterix Corp Stock, NASDAQ:QTRX

Building 1, 900 Middlesex Turnpike, Billerica, Massachusetts 01821
United States of America
Phone: +1.617.301.9400
Number of Employees: 314

Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.